Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.
Press releases published on August 5, 2025
Osteogenesis – Angiogenesis Coupling via Interlineage Paracrine Signaling
EIN Presswire
·
August 5, 2025
Single-cell transcriptomics reveal a distinct type of progenitor cell that supports angiogenesis and odontogenesis, leading to periodontal bone regeneration. CHINA, August 5, 2025 /EINPresswire.com/ -- The precise mechanism of cellular condensation and …
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
GlobeNewswire
·
August 5, 2025
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food …
Global Contrast Media Injectors Market Is Expected to Reach $2.60 Billion by 2030
EIN Presswire
·
August 5, 2025
Increasing prevalence of cancer and cardiovascular diseases and rise in unhealthy lifestyle drive the growth of the global contrast media injectors market. WILMINGTON, DE, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- According to the report …
Medical Supplies Industry on a 4% Growth Trajectory, Driven by Diagnostic Innovation and Resilient Supply Chains
EIN Presswire
·
August 5, 2025
New market data reveals a dynamic medical supplies sector poised for a 4% CAGR, offering manufacturers unique opportunities to drive growth and innovation NEW YORK, DE, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- In a healthcare landscape …
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
GlobeNewswire
·
August 5, 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
GlobeNewswire
·
August 5, 2025
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role …
Interior Designer Launches Fine Art Photography Venture for Commercial and Residential Spaces
EIN Presswire
·
August 5, 2025
CLEARWATER, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- After more than 35 years in interior design, Dina Marie is taking a new approach to transforming spaces—this time through the lens of her camera. The Florida-based designer has launched …
Ottimate Introduces Conversational AP, First AI Assistant To Proactively Assess & Optimize AP Operations
EIN Presswire
·
August 5, 2025
Ottimate Copilot responds to prompts for day-to-day operational tasks while offering proactive suggestions for optimizing cash flow …
Peer-Reviewed Study Confirms Within Health's Remote PHP/IOP Model Delivers Consistent Results Across Ages
EIN Presswire
·
August 5, 2025
Study confirms strong outcomes across all ages, validating Within Health’s intentionally-designed, fully remote model as a proven alternative to in‑person care. COCONUT GROVE, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Within Health, a …
US Navy Veterans Lung Cancer Advocate Appeals to Navy Veterans Who Now Have Lung Cancer Nationwide to Call About Significant Compensation that May Exceed $100,000 If They Were Exposed to Asbestos in The Navy Before 1983
EIN Presswire
·
August 5, 2025
WASHINGTON, DC, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The US Navy Veterans Lung Cancer Advocate says, "If you are a navy Veteran who has just been diagnosed with lung cancer, and you had routine exposure to asbestos in the navy before 1983 …
Dr. Sam Speron Discusses Pros and Cons of Surgical and Non-Surgical Facelifts
EIN Presswire
·
August 5, 2025
Dr. Sam Speron Discusses Pros and Cons of Surgical and Non-Surgical Facelifts CHICAGO, IL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Reconstructive surgeon, underscores the lasting advantages of traditional surgical facelifts over non- …
Business Reporter: Optimising hybrid multicloud environments
EIN Presswire
·
August 5, 2025
How advanced converge cloud technology can drive efficiency and sustainability LONDON, UNITED KINGDOM, August 5, 2025 /EINPresswire.com/ -- In an article published on Business Reporter, Sammy Zoghlami, SVP EMEA at Nutanix explains how hyperconverged …
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
GlobeNewswire
·
August 5, 2025
MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …
Galecto Reports Second Quarter 2025 Operating and Financial Results
GlobeNewswire
·
August 5, 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
Fractyl Health Announces Proposed Public Offering
GlobeNewswire
·
August 5, 2025
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T2D”), …
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
GlobeNewswire
·
August 5, 2025
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional …
Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update
GlobeNewswire
·
August 5, 2025
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial demonstrates 63% response rate observed among 43 evaluable patients and 79% overall survival rate at 12-months - Based on the Company’s current operating plan, existing …
Supernus Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
Net sales of Qelbree® increased 31% in the second quarter of 2025, compared to the same period in 2024. Net sales of Qelbree of $77.6 million and $142.3 million in the second quarter and first six months of 2025, respectively. Net sales of GOCOVRI® …
LeMaitre Q2 2025 Financial Results
GlobeNewswire
·
August 5, 2025
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q2 …
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
GlobeNewswire
·
August 5, 2025
CAMBRIDGE, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …